Results 1 to 1 of 1
Page 1 of 1
TypeTitleAuthor(s)YearViews
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia
Journal:
Blood
Publisher:
American Society of Hematology. The Journal's web site is located at http://bloodjournal.hematologylibrary.org/
Le Coutre, P; Ottmann, OG; Giles, F; Kim, DW; Cortes, J; Gattermann, N; Apperley, JF; Larson, RA; Abruzzese, E; O'Brien, SG; Kuliczkowski, K; Hochhaus, A; Mahon, FX; Saglio, G; Gobbi, M; Kwong, YL; Baccarani, M; Hughes, T; Martinelli, G; Radich, JP; Zheng, M; Shou, Y; Kantarjian, H2008229
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download